Detecting the expression of human endogenous retrovirus E envelope transcripts in human prostate adenocarcinoma

Cancer

Volumn 98, Issue 1, 2003, Pages 187-197

  Wang Johanning, Feng ^a   Frost, Andra R ^b   Jian, Bixi ^a   Azuero, Ricardo ^a   Lu, Danielle W ^c   Chen, Dung Tsa ^d   Johanning, Gary L ^d  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Envelope proteins; Human endogenous retrovirus; Novel tumor markers; Prostate carcinoma

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; EARLY DIAGNOSIS; ENVELOPE GENE; EPITHELIUM CELL; EUKARYOTE; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN ENDOGENOUS RETROVIRUS E; IMMUNOTHERAPY; IN SITU HYBRIDIZATION; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROKARYOTE; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOP CODON; VIRUS ENVELOPE;

BLOTTING, NORTHERN; DNA, COMPLEMENTARY; ENDOGENOUS RETROVIRUSES; GENE PRODUCTS, ENV; GENETIC VECTORS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0037663943     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11451     Document Type: Article

References (43)

1. Leib-Mosch C, Brack-Werner R, Werner T, et al. Endogenous retroviral elements in human DNA. Cancer Res. 1990;50(17 Suppl):5636S-55642S.
2. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409:860-921.
3. Tristem M. Identification and characterization of novel human endogenous retrovirus families by phylogenetic screening of the Human Genome Mapping Project database. J Virol. 2000;74:3715-3730.
4. Larsson E, Kato N, Cohen M. Human endogenous proviruses. Curr Top Microbiol Immunol. 1989;148:115-132.
5. Ono M, Yasunaga T, Miyata T, Ushikubo H. Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome. J Virol. 1986;60:589-598.
6. Lindeskog M, Medstrand P, Cunningham AA, Blomberg J. Coamplification and dispersion of adjacent human endogenous retroviral HERV-H and HERV-E elements; presence of spliced hybrid transcripts in normal leukocytes. Virology. 1998;244:219-229.
7. Steele PE, Martin MA, Rabson AB, Bryan T, O'Brien SJ. Amplification and chromosomal dispersion of human endogenous retroviral sequences. J Virol. 1986;59:545-550.
8. Kitamura M, Maruyama N, Shirasawa T, et al. Expression of an endogenous retroviral gene product in human placenta. Int J Cancer. 1994;58:836-840.
9. Turbeville MA, Rhodes JC, Hyams DM, Distler CM, Steele PE. Characterization of a putative retroviral env-related human protein. Pathobiology. 1997;65:123-128.
10. O'Connell C, O'Brien S, Nash WG, Cohen M. ERV3, a full-length human endogenous provirus: chromosomal localiza-tion and evolutionary relationships. Virology. 1984;138:225-235.
11. O'Connell CD, Cohen M. The long terminal repeat sequences of a novel human endogenous retrovirus. Science. 1984;226:1204-1206.
12. Cohen M, Powers M, O'Connell C, Kato N. The nucleotide sequence of the env gene from the human provirus ERV3 and isolation and characterization of an ERV3-specific cDNA. Virology. 1985;147:449-458.
13. Andersson AC, Merza M, Venables P, et al. Elevated levels of the endogenous retrovirus ERV3 in human sebaceous glands. J Invest Dermatol. 1996;106:125-128.
14. Boyd MT, Bax CM, Bax BE, Bloxam DL, Weiss RA. The human endogenous retrovirus ERV-3 is upregulated in differentiating placental trophoblast cells. Virology. 1993;196:905-909.
15. Li JM, Fan WS, Horsfall AC, et al. The expression of human endogenous retrovirus-3 in fetal cardiac tissue and antibodies in congenital heart block. Clin Exp Immunol. 1996;104: 388-393.
16. Larsson E, Andersson AC, Nilsson BO. Expression of an endogenous retrovirus (ERV3 HERV-R) in human reproductive and embryonic tissues - evidence for a function for envelope gene products. Ups J Med Sci. 1994;99:113-120.
17. Katsumata K, Ikeda H, Sato M, et al. Cytokine regulation of env gene expression of human endogenous retrovirus-R in human vascular endothelial cells. Clin Immunol. 1999;93:75-80.
18. Lower R, Boller K, Hasenmaier B, et al. Identification of human endogenous retroviruses with complex mRNA expression and particle formation. Proc Natl Acad Sci U S A. 1993;90:4480-4484.
19. Lower R, Tonjes RR, Korbmacher C, Kurth R, Lower J. Identification of a Rev-related protein by analysis of spliced transcripts of the human endogenous retroviruses HTDV/HERV-K. J Virol. 1995;69:141-149.
20. Herbst H, Sauter M, Mueller-Lantzsch N. Expression of human endogenous retrovirus K elements in germ cell and trophoblastic tumors. Am J Pathol. 1996;149:1727-1735.
21. Herbst H, Sauter M, Kuhler-Obbarius C, Loning T, Mueller-Lantzsch N. Human endogenous retrovirus (HERV)-K transcripts in germ cell and trophoblastic tumours. APMIS. 1998;106:216-220.
22. Herbst H, Kuhler-Obbarius C, Lauke H, et al. Human endogenous retrovirus (HERV)-K transcripts in gonadoblastomas and gonadoblastoma-derived germ cell tumours. Virchows Arch. 1999;434:11-15.
23. Lower R, Lower J, Frank H, Harzmann R, Kurth R. Human teratocarcinomas cultured in vitro produce unique retrovirus-like viruses. J Gen Virol. 1984;65(Pt 5):887-898.
24. Lower R, Lower J, Kurth R. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci U S A. 1996;93: 5177-5184.
25. Patience C, Simpson GR, Colletta AA, Welch HM, Weiss RA, Boyd MT. Human endogenous retrovirus expression and reverse transcriptase activity in the T47D mammary carcinoma cell line. J Virol. 1996;70:2654-2657.
26. Natoli F, Crowley MR, Asch HL, Stoler DL, Asch BB. Mutations involving the endogenous ecotropic murine leukemia virus in primary mammary carcinomas of BALB/c mice. Cancer Lett. 1996;99:121-127.
27. Asch BB, Asch HL, Stoler DL, Anderson GR. De-regulation of endogenous retrotransposons in mouse mammary carcinomas of diverse etiologies. Int J Cancer. 1993;54:813-819.
28. Rabson AB, Hamagishi Y, Steele PE, Tykocinski M, Martin MA. Characterization of human endogenous retroviral envelope RNA transcripts. J Virol. 1985;56:176-182.
29. Ono M, Kawakami M, Ushikubo H. Stimulation of expression of the human endogenous retrovirus genome by female steroid hormones in human breast cancer cell line T47D. J Virol. 1987;61:2059-2062.
30. Wang-Johanning F, Frost AR, Johanning GL, et al. Expression of human endogenous retrovirus k envelope transcripts in human breast cancer. Clin Cancer Res. 2001;7:1553-1560.
31. Repaske R, Steele PE, O'Neill RR, Rabson AB, Martin MA. Nucleotide sequence of a full-length human endogenous retroviral segment. J Virol. 1985;54:764-772.
32. National Center for Biotechnology Information. GenBank [database online]. Available from URL: http://www.ncbi.nlm.nih.gov/Genbank/index.html [accessed 7 January 2003].
33. Mayer J, Sauter M, Racz A, Scherer D, Mueller-Lantzsch N, Meese E. An almost-intact human endogenous retrovirus K on human chromosome 7. Nat Genet. 1999;21:257-258.
34. Rosner B. Fundamentals of biostatistics. Version 5. Pacific Grove: Duxbury, 2000.
35. Boese A, Sauter M, Galli U, et al. Human endogenous retrovirus protein cORF supports cell transformation and associates with the promyelocytic leukemia zinc finger protein. Oncogene. 2000;19:4328-4336.
36. Tamura N, Suzuki K, Iwase A, Yamamoto T, Kira S. [Retroviral infection as a putative pathogen for sarcoidosis]. Nippon Rinsho. 1994;52:1503-1507.
37. Kershaw MH, Hsu C, Mondesire W, et al. Immunization against endogenous retroviral tumor-associated antigens. Cancer Res. 2001;61:7920-7924.
38. Yang JC, Perry-Lalley D. The envelope protein of an endogenous murine retrovirus is a tumor-associated T-cell antigen for multiple murine tumors. J Immunother. 2000;23:177-183.
39. Mangeney M, de Parseval N, Thomas G, Heidmann T. The full-length envelope of an HERV-H human endogenous retrovirus has immunosuppressive properties. J Gen Virol. 2001;82(Pt 10):2515-2518.
40. Seifarth W, Skladny H, Krieg-Schneider F, Reichert A, Hehlmann R, Leib-Mosch C. Retrovirus-like particles released from the human breast cancer cell line T47-D display type B- and C-related endogenous retroviral sequences. J Virol. 1995;69:6408-6416.
41. Honda A, Nishimura S. Suppression of translation frameshift by upstream termination codon. Biochem Biophys Res Commun. 1996;221:602-608.
42. Enssle J, Jordan I, Mauer B, Rethwilm A. Foamy virus reverse transcriptase is expressed independently from the Gag protein. Proc Natl Acad Sci U S A. 1996;93:4137-4141.
43. Wang-Johanning F, Frost AR, Jian B, Epp L, Lu DW, Johanning GL. Quantitation of HERV-K gene expression and splicing in human breast cancer. Oncogene. 2003;22:1528-1535.